Provided by Tiger Fintech (Singapore) Pte. Ltd.

Protagenic Therapeutics Inc

2.94
-0.2500-7.84%
Volume:92.23K
Turnover:281.93K
Market Cap:2.55M
PE:-0.19
High:3.25
Open:3.25
Low:2.90
Close:3.19
Loading ...

Company Profile

Company Name:
Protagenic Therapeutics Inc
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
701 Anacapa Street,Suite C,Santa Barbara,California,United States
Zip Code:
93101
Fax:
- -
Introduction:
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

Directors

Name
Position
Barrett Evans
Director, President and Chief Executive Officer
Garo H. Armen
Executive Chairman of the Board
Brian Corvese
Independent Director
Colin Stott
Chief Operating Officer and Director
Jennifer Buell
Independent Director
Timothy R. Wright
Independent Director
Jennifer Chao
Director

Shareholders

Name
Position
Barrett Evans
Director, President and Chief Executive Officer
Colin Stott
Chief Operating Officer and Director
Alexander K. Arrow
Chief Financial Officer
Andrew Slee
Chief Development Officer
Garo H. Armen
Executive Chairman of the Board
Robert B. Stein
Chief Medical Officer